RLN2 and Hypertension: Moreover, future works should evaluate relaxin-2 plasma levels in patients with CAVS-induced hypertension and with non-CAVS-related hypertension since this syndrome constitutes a known risk factor for CAVS and the calcification of the aortic valve could lead to the development of hypertension [143].